NCT05890417 Evolution of Sexual Life Quality of Women With POI Before and After Introduction of Hormone Replacement Therapy
| NCT ID | NCT05890417 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Premature Ovarian Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 135 participants |
| Start Date | 2023-07-17 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 135 participants in total. It began in 2023-07-17 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the evolution of quality of sex life of women with POI after introduction hormone replacement therapy through the FSFI scale
Eligibility Criteria
Inclusion Criteria: * positive diagnosis of POI (amenorrhea \> 4 months or spaniomenorrhea \> 4 months and FSH \> 25 IU/L checked twice, more than 4 weeks apart) * absence of hormonal treatment, * patient's oral consent, * affiliated or beneficiary of health insurance Exclusion Criteria: * contraindication to hormonal treatment (history of hormone-dependent cancer, history of ischemic arterial stroke), * inability of the patient to understand the nature or risks or significance and implications of the clinical investigation, * patient under legal protection
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05890417 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Premature Ovarian Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05890417 currently recruiting?
Yes, NCT05890417 is actively recruiting participants. Contact the research team at valerie.bernard@chu-bordeaux.fr for enrollment information.
Where is the NCT05890417 trial being conducted?
This trial is being conducted at Bordeaux, France.
Who is sponsoring the NCT05890417 clinical trial?
NCT05890417 is sponsored by University Hospital, Bordeaux. The trial plans to enroll 135 participants.